XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Preferred Stock Series A [Member]
Preferred Stock Series B [Member]
Common Stock [Member]
Stock Payable [Member]
Share Subscription Receivable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Oct. 31, 2023 $ 5,000 $ 419,341 $ 32,251 $ (23,750) $ 41,470,177 $ (42,096,104) $ (193,085)
Beginning balance, shares at Oct. 31, 2023 5,000,000 419,341,584          
Regulation A stock issuances $ 92 33,999 91,409 125,500
Regulation A stock issuances, shares     91,501          
Net loss (507,073) (507,073)
Ending balance, value at Jan. 31, 2024 $ 5,000 $ 419,433 66,250 (23,750) 41,561,586 (42,603,177) (574,658)
Ending balance, shares at Jan. 31, 2024 5,000,000 419,433,085          
Beginning balance, value at Oct. 31, 2023 $ 5,000 $ 419,341 32,251 (23,750) 41,470,177 (42,096,104) (193,085)
Beginning balance, shares at Oct. 31, 2023 5,000,000 419,341,584          
Net loss               (1,573,512)
Ending balance, value at Jul. 31, 2024 $ 5,000 $ 410,739 17,750 (13,750) 42,175,208 (43,669,616) (1,074,669)
Ending balance, shares at Jul. 31, 2024 5,000,000 410,739,392          
Beginning balance, value at Jan. 31, 2024 $ 5,000 $ 419,433 66,250 (23,750) 41,561,586 (42,603,177) (574,658)
Beginning balance, shares at Jan. 31, 2024 5,000,000 419,433,085          
Regulation A stock issuances $ 120 13,250 120,280 133,650
Regulation A stock issuances, shares     120,400          
Net loss (570,855) (570,855)
Ending balance, value at Apr. 30, 2024 $ 5,000 $ 419,553 79,500 (23,750) 41,681,866 (43,174,032) (1,011,863)
Ending balance, shares at Apr. 30, 2024 5,000,000 419,553,485          
Regulation A stock issuances $ 219 (61,750) 218,809 157,278
Regulation A stock issuances, shares     219,028          
Regulation D stock issuances $ 967 274,533 275,500
Regulation D stock issuances, shares     966,879          
Shares cancelled as per settlement agreement - Vivaris Capital $ (10,000) 10,000
Shares cancelled as per settlement agreement - Vivaris Capital, shares     (10,000,000)          
Net loss (495,584) (495,584)
Ending balance, value at Jul. 31, 2024 $ 5,000 $ 410,739 17,750 (13,750) 42,175,208 (43,669,616) (1,074,669)
Ending balance, shares at Jul. 31, 2024 5,000,000 410,739,392          
Beginning balance, value at Oct. 31, 2024 $ 5,000 $ 419,438 15,250 (13,750) 43,611,365 (45,434,694) (1,397,391)
Beginning balance, shares at Oct. 31, 2024 5,000,000 419,437,865          
Regulation D stock issuances $ 29 14,971 15,000
Regulation D stock issuances, shares     29,293          
Shares cancelled as per exchange agreement $ (360,000) (360,000)
Shares cancelled as per exchange agreement, shares     (360,000,000)          
Series B preferred stock issuances $ 360 359,640 360,000
Series B preferred stock issuances, shares   360,000            
Stock-based compensation $ 16,125 5,076,432 5,092,557
Stock-based compensation, shares     16,125,000          
Net loss (5,461,393) (5,461,393)
Ending balance, value at Jan. 31, 2025 $ 5,000 $ 360 $ 75,592 15,250 (13,750) 49,062,408 (50,896,087) (1,751,227)
Ending balance, shares at Jan. 31, 2025 5,000,000 360,000 75,592,158          
Beginning balance, value at Oct. 31, 2024 $ 5,000 $ 419,438 15,250 (13,750) 43,611,365 (45,434,694) (1,397,391)
Beginning balance, shares at Oct. 31, 2024 5,000,000 419,437,865          
Net loss               (6,429,469)
Ending balance, value at Jul. 31, 2025 $ 5,000 $ 360 $ 95,920 15,250 (13,750) 50,204,960 (51,864,163) (1,556,423)
Ending balance, shares at Jul. 31, 2025 5,000,000 360,000 95,920,491          
Beginning balance, value at Jan. 31, 2025 $ 5,000 $ 360 $ 75,592 15,250 (13,750) 49,062,408 (50,896,087) (1,751,227)
Beginning balance, shares at Jan. 31, 2025 5,000,000 360,000 75,592,158          
Regulation D stock issuances $ 4,558 522,942 527,500
Regulation D stock issuances, shares     4,558,333          
Net loss (470,066) (470,066)
Ending balance, value at Apr. 30, 2025 $ 5,000 $ 360 $ 80,150 15,250 (13,750) 49,585,350 (51,366,153) (1,693,793)
Ending balance, shares at Apr. 30, 2025 5,000,000 360,000 80,150,491          
Regulation D stock issuances $ 13,190 380,810 394,000
Regulation D stock issuances, shares     13,190,000          
Stock-based compensation $ 2,580 238,800 241,380
Stock-based compensation, shares     2,580,000          
Net loss (498,010) (498,010)
Ending balance, value at Jul. 31, 2025 $ 5,000 $ 360 $ 95,920 $ 15,250 $ (13,750) $ 50,204,960 $ (51,864,163) $ (1,556,423)
Ending balance, shares at Jul. 31, 2025 5,000,000 360,000 95,920,491